Purpose: Although hypoxia is considered a major cause of failure of radioth
erapy, the mechanisms of tumor hypoxia are unclear, and effective ways for
its correction or targeting are missing. Tumoral vasculature is the vehicle
for the hemoglobin to reach the tumoral stroma, Although anemia has long b
een focused on as an important parameter related to tumor hypoxia, differen
ces in vascular density may also affect the intratumoral access of hemoglob
in.
Methods and Materials: In the present study, we examined the vascular densi
ty in 1459 human carcinomas. The distribution of the vascular density withi
n tumors was studied in 436 non-small-cell lung carcinomas and 298 breast c
arcinomas. Results: The vascular density was found to vary up to 22-fold ev
en among tumors of the same histology.
Overall, the vascular density was significantly higher in the tumor periphe
ry as compared to inner areas, Three different patterns of vascularization
were identified in both lung and breast cancer specimens; (I) tumors with l
ow or (2) tumors with high vessel density throughout the tissue section, an
d (3) tumors with high vessel density in the tumor periphery and low in inn
er areas. The death rate following surgery showed a direct association with
the vascular density in lung, breast, colon, and endometrial cancer, In in
operable gastric cancer patients treated with chemotherapy, and in head and
neck cancer patients treated with radical chemoradiotherapy there was a 'U
-like' association of the death rate with the vascular density suggesting t
hat very low (poor oxygen and drug availability) and very high (intensified
angiogenic pathways) vascularization are both linked to poor outcome.
Conclusion: The present study stresses the importance of the vascular densi
ty as a putative variable that may have affected the results of large clini
cal trials that investigated the role of anemia, hyperbaric oxygen, hypoxic
sensitizers, or even of combined chemoradiotherapy in the outcome of radia
tion treatment. (C) 2000 Elsevier Science Inc.